1. Home
  2. SCM vs RCEL Comparison

SCM vs RCEL Comparison

Compare SCM & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • RCEL
  • Stock Information
  • Founded
  • SCM 2012
  • RCEL 2020
  • Country
  • SCM United States
  • RCEL United States
  • Employees
  • SCM N/A
  • RCEL N/A
  • Industry
  • SCM Finance/Investors Services
  • RCEL Medical/Dental Instruments
  • Sector
  • SCM Finance
  • RCEL Health Care
  • Exchange
  • SCM Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • SCM 370.0M
  • RCEL 310.6M
  • IPO Year
  • SCM 2012
  • RCEL N/A
  • Fundamental
  • Price
  • SCM $13.98
  • RCEL $11.95
  • Analyst Decision
  • SCM Hold
  • RCEL Hold
  • Analyst Count
  • SCM 2
  • RCEL 3
  • Target Price
  • SCM $13.63
  • RCEL $16.50
  • AVG Volume (30 Days)
  • SCM 161.4K
  • RCEL 99.4K
  • Earning Date
  • SCM 11-07-2024
  • RCEL 11-07-2024
  • Dividend Yield
  • SCM 11.44%
  • RCEL N/A
  • EPS Growth
  • SCM 307.51
  • RCEL N/A
  • EPS
  • SCM 1.96
  • RCEL N/A
  • Revenue
  • SCM $107,143,385.00
  • RCEL $60,040,000.00
  • Revenue This Year
  • SCM $2.75
  • RCEL $34.73
  • Revenue Next Year
  • SCM $1.08
  • RCEL $54.61
  • P/E Ratio
  • SCM $7.14
  • RCEL N/A
  • Revenue Growth
  • SCM 5.88
  • RCEL 32.24
  • 52 Week Low
  • SCM $12.48
  • RCEL $7.51
  • 52 Week High
  • SCM $14.68
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • SCM 53.18
  • RCEL 57.86
  • Support Level
  • SCM $13.65
  • RCEL $11.16
  • Resistance Level
  • SCM $14.14
  • RCEL $13.37
  • Average True Range (ATR)
  • SCM 0.22
  • RCEL 0.72
  • MACD
  • SCM -0.02
  • RCEL 0.12
  • Stochastic Oscillator
  • SCM 63.22
  • RCEL 57.23

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. Business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: